Prosecution Insights
Last updated: August 18, 2026

Examiner: MOSS, NATALIE M

Tech Center 1600 • Art Units: 1653

This examiner grants 31% of resolved cases

Performance Statistics

30.9%
Allow Rate
-29.1% vs TC avg
599
Total Applications
+16.7%
Interview Lift
1406
Avg Prosecution Days
Based on 517 resolved cases, 2023–2026

Rejection Statute Breakdown

8.0%
§101 Eligibility
13.6%
§102 Novelty
45.1%
§103 Obviousness
29.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17964325 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION Non-Final OA Genentech, Inc.
17213417 COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION Final Rejection DANA-FARBER CANCER INSTITUTE, INC.
18227801 Methods for Antimicrobial Susceptibility Testing Final Rejection The Regents of the University of California
17280486 ASSAYS FOR CELL-BASED THERAPIES OR TREATMENTS Non-Final OA The Regents of the University of California
17607695 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS Final Rejection Regents of the University of Minnesota
18359053 METHOD FOR PROMOTING PROLIFERATION AND PLURIPOTENCY FACTOR EXPRESSION OF STEM CELLS AND COMPOSITION PRODUCED USING THE SAME Final Rejection BUDDHIST TZU CHI MEDICAL FOUNDATION
18648537 COMPOSITION FOR CELL ADDITION Non-Final OA AGC INC.
17439251 ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF Non-Final OA Massachusetts Institute of Technology
18237744 NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY Non-Final OA The Johns Hopkins University
17602458 CELL CULTURE MEDIA COMPRISING KETO ACIDS Non-Final OA MERCK PATENT GMBH
18277278 CELL SHEET SUPPORT, CELL SHEET LAMINATE AND METHOD FOR PRODUCING SAME Final Rejection FUKUOKA UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month